...
...
News / Topic / Dcgi / News
[

dcgi news

]

Drug regulator suspends product PresVu over unauthorised promotion

DCGI suspended PresVu after the company failed to respond to the queries.
health
Published on Sep 12, 2024 09:00 AM IST

DCGI suspends Entod’s marketing approval for PresVu eye drops amid misuse concerns

Entod was aiming at an October launch in the Indian market. (Representative file photo)
india news
Published on Sep 11, 2024 07:48 PM IST

Amazon, Flipkart issued notices for selling drugs without licence: Report

(Representational Image/HT file)
business
Updated on Feb 12, 2023 07:37 PM IST

'Compliant with norms': India to WHO on cough syrups and Gambia kids' deaths

Sonepat: Maiden Pharmaceuticals Limited factory in Sonepat district, Thursday, Oct. 6, 2022. A probe has been initiated by India's drug regulator after WHO issued an alert saying cough syrups manufactured by the Indian firm could potentially be linked to the death of children in Gambia. (PTI Photo)(PTI10_06_2022_000103B) (PTI)
india news
Updated on Dec 16, 2022 12:16 PM IST

Gambia deaths: India says WHO's info ‘inadequate’ to determine aetiology

Mariama Kuyateh, 30, holds up a picture of her late son Musawho died from acute kidney failure, in Banjul, 
india news
Updated on Oct 15, 2022 11:54 PM IST

‘Diligently following protocol’: Maiden Pharma breaks silence on Gambia deaths

A health department team arrives at the Maiden Pharmaceuticals Ltd unit in Sonepat. (PTI)
india news
Updated on Oct 09, 2022 05:32 AM IST

Covovax granted EUA for children aged 7-12

Jalandhar: A health worker administers a dose of COVID-19 vaccine to a student, amid rise in coronavirus cases, at a government school, in Jalandhar, Monday, May 2, 2022. (PTI Photo) (PTI05_02_2022_000108B) (PTI)
india news
Updated on Jun 29, 2022 01:34 AM IST

India clears Corbevax as a booster dose for adults

So far, 51.7 million doses of Corbevax have been administered to children across the country (FILE)
india news
Published on Jun 05, 2022 12:07 AM IST

Govt’s expert panel likely to review Covovax data

A healthcare worker administers a dose of the Covid-19 vaccine to a student in the age group of 12-14 years, at a school in Vasundhara, in Ghaziabad on Wednesday. (PTI)
india news
Updated on Mar 31, 2022 04:05 AM IST

DCGI approves trials for internasal booster dose

The phase 3 trials will be conducted as randomised open label multi-center study to compare immunogenicity and safety of BBV154 with Covaxin. (File/Representative use)
india news
Published on Jan 29, 2022 04:45 AM IST

SEC recommends Covaxin, Covishield for full market authorisation: Report

A doctor being inoculated with a booster dose of Covid-19 vaccine, at Ganga Ram Hospital, in New Delhi. (Amal KS/HT Photo)
india news
Updated on Jan 19, 2022 10:44 PM IST

DCGI needs more safety data for Covaxin nod for under 12

A Municipal Corporation worker administers a dose of Covid-19 vaccine to a teenager, at a municipal school in Thane. (PTI)
india news
Updated on Jan 18, 2022 04:45 AM IST

2 new vaccines, Covid pill approved for use

Representative Image
india news
Published on Dec 29, 2021 12:21 AM IST

DCGI approves Covaxin for emergency use in age group between 12 and 18 years

The Drugs Controller General of India (DCGI) on Saturday granted approval for restricted use in emergency situation to Bharat Biotech’s Covaxin in the paediatric age group between 12 and 18 years. (HT PHOTO.)
india news
Updated on Dec 26, 2021 01:12 AM IST

Serum Institute seeks DCGI nod for Covishield booster shot amid Omicron scare

Prakash Kumar Singh, director of government and regulatory affairs at Pune-based SII, mentioned in his letter to DCGI that the UK’s Medicines and Healthcare products regulatory agency has already approved the booster doses of AstraZeneca ChAdOx1 nCoV-19 vaccine.
pune news
Published on Dec 02, 2021 02:42 AM IST

Govt allows SII to export 5 crore doses of Covid-19 vaccine Covovax to Indonesia

Adar Poonawalla, chief executive officer of Serum Institute of India. (File photo)
pune news
Published on Nov 15, 2021 11:17 PM IST

Bharat Biotech submits data from Covaxin's trials on children to DCGI: Report

Bharat Biotech International Limited's Covaxin (HT File Photo)
india news
Published on Oct 03, 2021 10:30 AM IST

DCGI accepts proposal to study mixing of Covid-19 vaccine doses

Representative Image
india news
Published on Aug 11, 2021 10:24 AM IST

Zydus Cadila submits additional data on its Covid-19 vaccine to DCGI: Report

A Covid-19 vaccination centre in Kolkata (ANI/used only for representative purpose)
india news
Published on Jul 27, 2021 08:36 PM IST

Bharat Biotech submits Covaxin phase 3 trials data to DCGI: Reports

A health worker holding up a vial of Covaxin, a Covid-19 vaccine at a school being used as a vaccination site in Kingsway Camp, Delhi (Sanchit Khanna / HT PHOTO),
india news
Published on Jun 22, 2021 09:50 AM IST

Ready to face whatever the court decides: Gautam Gambhir on drug hoarding case

The drug controller told the Delhi high court on Friday that Gautam Gambhir Foundation had committed an offence under Drugs and Cosmetics Act
delhi news
Published on Jun 04, 2021 08:55 PM IST

Serum seeks DCGI nod to manufacture Sputnik

Vaccination centre at Dr. Babasaheb Ambedkar Hospital (Shatabdi Hospital) closed due vaccine shortage at Kandivali, in Mumbai.
india news
Updated on Jun 04, 2021 04:36 AM IST

'A new weapon': Dr Naresh Trehan on Covid-19 antibody cocktail

The cocktail of casirivimab and imdevimab has been developed by Swiss pharmaceutical giant Roche.
india news
Published on May 26, 2021 05:12 PM IST

DCGI gives emergency approval of DRDO-developed anti-Covid oral drug

Responding to Prime Minister Narendra Modi’s call for preparedness against the pandemic, the DRDO took the initiative of developing anti-Covid therapeutic application of 2-DG
india news
Published on May 08, 2021 03:30 PM IST
View more
Sign in
Sign out
Subscribe Now
Copyright © HT Digital Streams Ltd. All rights reserved.